GSK plc — RNS

Regulatory news across GSK, GSK

Date	TIDM	Time	Date	TIDM	TitleTitle (filtered)	Company	Source
12/06/25	GSK	11:00:00	12 Jun 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK plc	PRN
20/10/23	GSK	15:30:01	20 Oct 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
18/10/23	GSK	15:30:00	18 Oct 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
17/10/23	GSK	15:30:01	17 Oct 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
16/10/23	GSK	07:00:08	16 Oct 2023	Jemperli plus chemotherapy positive CHMP opinion	GSK	Jemperli plus chemotherapy positive CHMP opinion	GSK PLC	RNS
13/10/23	GSK	15:30:00	13 Oct 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
12/10/23	GSK	15:30:01	12 Oct 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
11/10/23	GSK	07:00:03	11 Oct 2023	Zantac (ranitidine) litigation	GSK	Zantac (ranitidine) litigation	GSK PLC	RNS
09/10/23	GSK	07:00:10	9 Oct 2023	GSK and Zhifei announce vaccine partnership	GSK	GSK and Zhifei announce vaccine partnership	GSK PLC	RNS
06/10/23	GSK	07:00:02	6 Oct 2023	GSK completes sale of shares in Haleon plc	GSK	GSK completes sale of shares in Haleon plc	GSK PLC	RNS
05/10/23	GSK	16:46:57	5 Oct 2023	GSK announces intention to sell shares in Haleon	GSK	GSK announces intention to sell shares in Haleon	GSK PLC	RNS
02/10/23	GSK	15:00:02	2 Oct 2023	Total Voting Rights	GSK	Total Voting Rights	GSK PLC	RNS
27/09/23	GSK	15:00:02	27 Sept 2023	Directorate Change	GSK	Directorate Change	GSK PLC	RNS
25/09/23	GSK	07:00:02	25 Sept 2023	GSK RSV vaccine for older adults approved in Japan	GSK	GSK RSV vaccine for older adults approved in Japan	GSK PLC	RNS
21/09/23	GSK	15:30:01	21 Sept 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
19/09/23	GSK	07:00:03	19 Sept 2023	Apretude for PrEP receives EMA approval	GSK	Apretude for PrEP receives EMA approval	GSK PLC	RNS
18/09/23	GSK	07:00:02	18 Sept 2023	FDA approves Ojjaara (momelotinib)	GSK	FDA approves Ojjaara (momelotinib)	GSK PLC	RNS
13/09/23	GSK	15:30:02	13 Sept 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
11/09/23	GSK	15:30:01	11 Sept 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
11/09/23	GSK	07:00:02	11 Sept 2023	Momelotinib filing accepted in Japan	GSK	Momelotinib filing accepted in Japan	GSK PLC	RNS
06/09/23	GSK	15:30:01	6 Sept 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
01/09/23	GSK	15:00:01	1 Sept 2023	Total Voting Rights	GSK	Total Voting Rights	GSK PLC	RNS
01/09/23	GSK	07:00:04	1 Sept 2023	GSK’s Nucala CRSwNP submission accepted in Japan	GSK	GSK’s Nucala CRSwNP submission accepted in Japan	GSK PLC	RNS
31/08/23	GSK	15:16:50	31 Aug 2023	Holding(s) in Company	GSK 42SB	Holding(s) in Company	GSK PLC Goldman Sachs Group Inc (The)	RNS
31/08/23	GSK	15:14:28	31 Aug 2023	Holding(s) in Company	GSK 42SB	Holding(s) in Company	GSK PLC Goldman Sachs Group Inc (The)	RNS
25/08/23	GSK	15:30:01	25 Aug 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
23/08/23	GSK	15:30:01	23 Aug 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
23/08/23	GSK	07:00:02	23 Aug 2023	Shingrix data demonstrate 100% efficacy in China	GSK	Shingrix data demonstrate 100% efficacy in China	GSK PLC	RNS
22/08/23	GSK	15:30:01	22 Aug 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
10/08/23	GSK	15:30:01	10 Aug 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
09/08/23	GSK	15:30:01	9 Aug 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
01/08/23	GSK	15:00:01	1 Aug 2023	Total Voting Rights	GSK	Total Voting Rights	GSK PLC	RNS
31/07/23	GSK	18:00:29	31 Jul 2023	FDA approves new use for Jemperli plus chemo	GSK	FDA approves new use for Jemperli plus chemo	GSK PLC	RNS
31/07/23	GSK	15:30:01	31 Jul 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
28/07/23	GSK	15:30:01	28 Jul 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
26/07/23	GSK	07:00:06	26 Jul 2023	2nd Quarter Results	GSK	2nd Quarter Results	GSK PLC	RNS
24/07/23	GSK	07:00:02	24 Jul 2023	Cabotegravir LA for PrEP receives positive CHMP	GSK	Cabotegravir LA for PrEP receives positive CHMP	GSK PLC	RNS
20/07/23	GSK	15:30:01	20 Jul 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
17/07/23	GSK	15:30:01	17 Jul 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
13/07/23	GSK	15:30:01	13 Jul 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
03/07/23	GSK	15:00:01	3 Jul 2023	Total Voting Rights	GSK	Total Voting Rights	GSK PLC	RNS
28/06/23	GSK	15:43:12	28 Jun 2023	GSK completes acquisition of BELLUS Health	GSK	GSK completes acquisition of BELLUS Health	GSK PLC	RNS
27/06/23	GSK	07:00:04	27 Jun 2023	FDA Fast Track for Gonorrhoea Vaccine Candidate	GSK	FDA Fast Track for Gonorrhoea Vaccine Candidate	GSK PLC	RNS
26/06/23	GSK	07:05:01	26 Jun 2023	Shingrix approved in Japan for adults 18 and over	GSK	Shingrix approved in Japan for adults 18 and over	GSK PLC	RNS
26/06/23	GSK	07:00:01	26 Jun 2023	GSK daprodustat gains positive EMA CHMP opinion	GSK	GSK daprodustat gains positive EMA CHMP opinion	GSK PLC	RNS
23/06/23	GSK	15:37:03	23 Jun 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
23/06/23	GSK	15:33:00	23 Jun 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
23/06/23	GSK	15:30:01	23 Jun 2023	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
23/06/23	GSK	07:00:01	23 Jun 2023	Statement: Zantac (ranitidine) litigation	GSK	Statement: Zantac (ranitidine) litigation	GSK PLC	RNS
22/06/23	GSK	07:00:02	22 Jun 2023	GSK’s Arexvy recommended by ACIP	GSK	GSK’s Arexvy recommended by ACIP	GSK PLC	RNS

Showing 701–750 of 2,803 announcements